RCT | Haloperidol for the treatment of delirium in ICU patients did not significantly improve outcomes.

Haloperidol for the Treatment of Delirium in ICU Patients – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary on Twitter

In this randomized trial, treatment with haloperidol did not increase the number of days alive and out of the hospital among ICU patients with delirium. #LIVES2022 https://t.co/SCRUg3ff9X pic.twitter.com/0dInueHE76

— NEJM (@NEJM) October 26, 2022